13F HOLDINGS REPORT
Artia Global Partners LP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001937964-25-000003
Total Value
$279.8M
Positions
37
Other Managers
0
Confidential Omitted
No
Holdings (37)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SOLENO THERAPEUTICS INC | SLNO | 494,424 | $22.2M | 7.94% |
| 2 | MERUS N V | N5749R100 | 463,840 | $19.5M | 6.97% |
| 3 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 219,719 | $18.4M | 6.56% |
| 4 | ARCELLX INC | ACLX | 229,785 | $17.6M | 6.30% |
| 5 | NOVO-NORDISK A S | NONOF | 200,000 | $17.2M | 6.15% |
| 6 | NOVO-NORDISK A S | NONOF | 200,000 | $17.2M | 6.15% |
| 7 | NUVALENT INC | NUVL | 204,045 | $16.0M | 5.71% |
| 8 | VAXCYTE INC | PCVX | 162,255 | $13.3M | 4.75% |
| 9 | ALNYLAM PHARMACEUTICALS INC | ALNY | 56,400 | $13.3M | 4.74% |
| 10 | ASTRAZENECA PLC | AZN | 190,752 | $12.5M | 4.47% |
| 11 | REVOLUTION MEDICINES INC | RVMDW | 284,190 | $12.4M | 4.44% |
| 12 | VERONA PHARMA PLC | 925050106 | 255,318 | $11.9M | 4.24% |
| 13 | INSMED INC | INSM | 167,939 | $11.6M | 4.14% |
| 14 | PROTAGONIST THERAPEUTICS INC | PTGX | 293,851 | $11.3M | 4.05% |
| 15 | SPDR SER TR | 78464A870 | 100,000 | $9.0M | 3.22% |
| 16 | JANUX THERAPEUTICS INC | JANX | 162,976 | $8.7M | 3.12% |
| 17 | ARGENX SE | ARGX | 11,311 | $7.0M | 2.49% |
| 18 | NEUROCRINE BIOSCIENCES INC | NBIX | 45,000 | $6.1M | 2.20% |
| 19 | NOVO-NORDISK A S | NONOF | 50,000 | $4.3M | 1.54% |
| 20 | VIKING THERAPEUTICS INC | VKTX | 90,279 | $3.6M | 1.30% |
| 21 | RHYTHM PHARMACEUTICALS INC | RYTM | 50,000 | $2.8M | 1.00% |
| 22 | CRINETICS PHARMACEUTICALS IN | CRNX | 45,765 | $2.3M | 0.84% |
| 23 | ENLIVEN THERAPEUTICS INC | ELVN | 102,900 | $2.3M | 0.83% |
| 24 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 53,930 | $1.9M | 0.70% |
| 25 | VIRIDIAN THERAPEUTICS INC | VRDN | 100,000 | $1.9M | 0.69% |
| 26 | TG THERAPEUTICS INC | TGTX | 54,515 | $1.6M | 0.59% |
| 27 | EYEPOINT PHARMACEUTICALS INC | EYPT | 216,700 | $1.6M | 0.58% |
| 28 | XENON PHARMACEUTICALS INC | XENE | 40,000 | $1.6M | 0.56% |
| 29 | MEREO BIOPHARMA GROUP PLC | MREO | 421,359 | $1.5M | 0.53% |
| 30 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 54,285 | $1.4M | 0.50% |
| 31 | CENTESSA PHARMACEUTICALS PLC | CNTA | 80,380 | $1.3M | 0.48% |
| 32 | EDGEWISE THERAPEUTICS INC | EWTX | 50,000 | $1.3M | 0.48% |
| 33 | CHARLES RIV LABS INTL INC | 159864107 | 6,305 | $1.2M | 0.42% |
| 34 | TARSUS PHARMACEUTICALS INC | TARS | 20,811 | $1.2M | 0.41% |
| 35 | ASCENDIS PHARMA A/S | ASND | 7,440 | $1.0M | 0.37% |
| 36 | ANNEXON INC | ANNX | 172,226 | $883,519 | 0.32% |
| 37 | TECTONIC THERAPEUTIC INC | TECX | 16,650 | $768,731 | 0.27% |